A Randomized Trial of MDMA-Assisted Cognitive-Behavioural Conjoint Therapy (CBCT) Versus CBCT in Dyads in Which One Member Has Posttraumatic Stress Disorder (PTSD)
Phase: PHASE2 | Sponsor: Remedy | Compound: MDMA
- Status
- recruiting
- Institution
- Remedy
- Start date
- 2024-11-15
- End date
- 2026-12-31
- Registry ID
- NCT06044675
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.